These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 27818999)

  • 1. Percutaneous Transluminal Angioplasty in Patients with Peripheral Arterial Disease Does Not Affect Circulating Monocyte Subpopulations.
    Maga P; Mikolajczyk TP; Partyka L; Krzanowski M; Malinowski KP; Nizankowski R
    Biomed Res Int; 2016; 2016():2708957. PubMed ID: 27818999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased intermediate CD14
    Wildgruber M; Czubba M; Aschenbrenner T; Wendorff H; Hapfelmeier A; Glinzer A; Schiemann M; Zimmermann A; Eckstein HH; Berger H; Wohlgemuth WA; Meier R; Libby P; Zernecke A
    Atherosclerosis; 2016 Oct; 253():128-134. PubMed ID: 27615596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human Blood Monocyte Subsets: A New Gating Strategy Defined Using Cell Surface Markers Identified by Mass Cytometry.
    Thomas GD; Hamers AAJ; Nakao C; Marcovecchio P; Taylor AM; McSkimming C; Nguyen AT; McNamara CA; Hedrick CC
    Arterioscler Thromb Vasc Biol; 2017 Aug; 37(8):1548-1558. PubMed ID: 28596372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Standardized flow cytometry assay for identification of human monocytic heterogeneity and LRP1 expression in monocyte subpopulations: decreased expression of this receptor in nonclassical monocytes.
    Ferrer DG; Jaldín-Fincati JR; Amigone JL; Capra RH; Collino CJ; Albertini RA; Chiabrando GA
    Cytometry A; 2014 Jul; 85(7):601-10. PubMed ID: 24639232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The "Intermediate" CD14
    Wildgruber M; Aschenbrenner T; Wendorff H; Czubba M; Glinzer A; Haller B; Schiemann M; Zimmermann A; Berger H; Eckstein HH; Meier R; Wohlgemuth WA; Libby P; Zernecke A
    Sci Rep; 2016 Dec; 6():39483. PubMed ID: 27991581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating classical CD14++CD16- monocytes predict shorter time to initial treatment in chronic lymphocytic leukemia patients: Differential effects of immune chemotherapy on monocyte-related membrane and soluble forms of CD163.
    Lapuc I; Bolkun L; Eljaszewicz A; Rusak M; Luksza E; Singh P; Miklasz P; Piszcz J; Ptaszynska-Kopczynska K; Jasiewicz M; Kaminski K; Dabrowska M; Bodzenta-Lukaszyk A; Kloczko J; Moniuszko M
    Oncol Rep; 2015 Sep; 34(3):1269-78. PubMed ID: 26135617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of heterogeneity of human peripheral blood monocyte subsets on myocardial salvage in patients with primary acute myocardial infarction.
    Tsujioka H; Imanishi T; Ikejima H; Kuroi A; Takarada S; Tanimoto T; Kitabata H; Okochi K; Arita Y; Ishibashi K; Komukai K; Kataiwa H; Nakamura N; Hirata K; Tanaka A; Akasaka T
    J Am Coll Cardiol; 2009 Jul; 54(2):130-8. PubMed ID: 19573729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toll-like receptor expression on classic and pro-inflammatory blood monocytes after acute exercise in humans.
    Simpson RJ; McFarlin BK; McSporran C; Spielmann G; ó Hartaigh B; Guy K
    Brain Behav Immun; 2009 Feb; 23(2):232-9. PubMed ID: 18930806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating CD14
    Meeuwsen JAL; de Vries JJ; van Duijvenvoorde A; van der Velden S; van der Laan SW; van Koeverden ID; van de Weg SM; de Borst GJ; de Winther MPJ; Kuiper J; Pasterkamp G; Hoefer IE; de Jager SCA;
    J Mol Cell Cardiol; 2019 Feb; 127():260-269. PubMed ID: 30629987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increases in inflammatory and CD14
    Gainaru G; Papadopoulos A; Tsangaris I; Lada M; Giamarellos-Bourboulis EJ; Pistiki A
    Crit Care; 2018 Mar; 22(1):56. PubMed ID: 29499723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunosuppression and monocyte subsets.
    Rogacev KS; Zawada AM; Hundsdorfer J; Achenbach M; Held G; Fliser D; Heine GH
    Nephrol Dial Transplant; 2015 Jan; 30(1):143-53. PubMed ID: 25313167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restenosis after femoropopliteal PTA and elective stent implantation: predictive value of monocyte counts.
    Schillinger M; Exner M; Mlekusch W; Haumer M; Sabeti S; Ahmadi R; Schwarzinger I; Wagner O; Minar E
    J Endovasc Ther; 2003 Jun; 10(3):557-65. PubMed ID: 12932168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD14++ CD16+ HLA-DR+ Monocytes in Peripheral Blood are Quantitatively Correlated with the Severity of Pre-eclampsia.
    Tang MX; Zhang YH; Hu L; Kwak-Kim J; Liao AH
    Am J Reprod Immunol; 2015 Aug; 74(2):116-22. PubMed ID: 25850575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD14+ CD16+ monocytes rather than CD14+ CD51/61+ monocytes are a potential cytological marker of circulating osteoclast precursors in multiple myeloma. A preliminary study.
    Petitprez V; Royer B; Desoutter J; Guiheneuf E; Rigolle A; Marolleau JP; Kamel S; Guillaume N
    Int J Lab Hematol; 2015 Feb; 37(1):29-35. PubMed ID: 24661393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adsorptive depletion of elevated proinflammatory CD14+CD16+DR++ monocytes in patients with inflammatory bowel disease.
    Hanai H; Iida T; Takeuchi K; Watanabe F; Yamada M; Kikuyama M; Maruyama Y; Iwaoka Y; Hirayama K; Nagata S; Takai K
    Am J Gastroenterol; 2008 May; 103(5):1210-6. PubMed ID: 18177452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The CD14(bright) CD16+ monocyte subset is expanded in rheumatoid arthritis and promotes expansion of the Th17 cell population.
    Rossol M; Kraus S; Pierer M; Baerwald C; Wagner U
    Arthritis Rheum; 2012 Mar; 64(3):671-7. PubMed ID: 22006178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of CD163 and HLA-DR molecules on the monocytes in chronic lymphocytic leukemia patients.
    Kowalska W
    Folia Histochem Cytobiol; 2020; 58(1):17-24. PubMed ID: 32176313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leukocyte-platelet aggregates-a phenotypic characterization of different stages of peripheral arterial disease.
    Dopheide JF; Rubrech J; Trumpp A; Geissler P; Zeller GC; Bock K; Dünschede F; Trinh TT; Dorweiler B; Münzel T; Radsak MP; Espinola-Klein C
    Platelets; 2016 Nov; 27(7):658-667. PubMed ID: 27352829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flow cytometry evaluation of CD14/CD16 monocyte subpopulations in systemic sclerosis patients: a cross sectional controlled study.
    Schneider L; Marcondes NA; Hax V; da Silva Moreira IF; Ueda CY; Piovesan RR; Xavier R; Chakr R
    Adv Rheumatol; 2021 May; 61(1):27. PubMed ID: 34022965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-4 decreases the expression of the monocyte differentiation marker CD14, paralleled by an increasing accessory potency.
    Ruppert J; Friedrichs D; Xu H; Peters JH
    Immunobiology; 1991 Aug; 182(5):449-64. PubMed ID: 1717365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.